Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1560
http://purl.obolibrary.org/obo/NCIT_C1560
|
|---|---|
| Preferred Name | Brequinar |
| Definitions |
A synthetic quinolinecarboxylic acid analogue with antineoplastic properties. Brequinar inhibits the enzyme dihydroorotate dehydrogenase, thereby blocking de novo pyrimidine biosynthesis. This agent may also enhance the in vivo antitumor effect of antineoplastic agents such as 5-FU. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A synthetic quinolinecarboxylic acid analogue with antineoplastic properties. Brequinar inhibits the enzyme dihydroorotate dehydrogenase, thereby blocking de novo pyrimidine biosynthesis. This agent may also enhance the in vivo antitumor effect of antineoplastic agents such as 5-FU. (NCI04) |
|---|---|
| prefLabel | Brequinar
|
| label | Brequinar
|
| Has_Salt_Form | |
| PDQ_Closed_Trial_Search_ID | 40886
|
| code | C1560
|
| prefixIRI | NCIT:C1560
|
| in_subset |
See more
See less
|
| Preferred_Name | Brequinar
|
| FDA_UNII_Code | 5XL19F49H6
|
| Contributing_Source | FDA
|
| Chemical_Formula | C23H15F2NO2
|
| Maps_To | Brequinar
|
| CAS_Registry | 96187-53-0
|
| NCI_Drug_Dictionary_ID | 40886
|
| Legacy Concept Name | Brequinar
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 40886
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
|
| UMLS_CUI | C0280509
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |